September 16th 2021, 3:00pm
A first-of-its-kind trial underway in patients with penile cancer may lead to a more effective therapy sequence, potentially avoiding unnecessary surgery.
September 16th 2021, 1:00pm
Through the emotions and anxiety of cancer, she realized she was not living her life to the fullest, and that it isn't over yet.
September 15th 2021, 9:29pm
The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.
September 15th 2021, 9:00pm
Tecartus was the first CAR-T cell therapy to be approved for the treatment of recurrent mantle cell lymphoma. Now, more than a year after its approval, a doctor discusses his experience prescribing the drug.
September 15th 2021, 7:00pm
Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.
September 15th 2021, 5:00pm
A cancer survivor describes how survivors can help face their fears by connecting with each other.
September 15th 2021, 3:00pm
Monitoring, rather than immediately treating, patients with low-risk prostate cancer may be a better approach, says an expert from UCSF Helen Diller Family Comprehensive Cancer Center.
September 15th 2021, 1:18pm
Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.
September 15th 2021, 1:00pm
An expert explains the treatment options and personal life impacts of an essential thrombocythemia diagnosis.
September 14th 2021, 9:00pm
GC4419 plus radiation improved progression-free survival and time to distant metastases in patients with unresectable or borderline resectable locally advanced pancreatic cancer.
New Agent Can Improve BCG Response, Quality of Life in Bladder Cancer
How One Cancer Nurse Exhibits Compassion on a Daily Basis
What Patients With Testicular Cancer Should Know About Fertility
A Cancer Survivor Unpacks the Impacts of Society’s Labels: 'Am I a Victim or a Survivor?'
